FDA Meeting Notice: Data & Methods For Evaluating The Impact Of Opioid Formulations With Properties Designed To Deter Abuse In The Postmarket Setting: A Scientific Discussion Of Present & Future Capabilities; Public Workshop; Issues Paper; Request For Comments

On June 14, 2017, the Federal Food and Drug Administration (FDA) released this meeting notice regarding data and methods for evaluating the impact of opioid formulations with properties designed to deter abuse in the postmarket setting. The meeting is a public workshop featuring a scientific discussion of present and future capabilities, with issues paper presentation and a request for comments following the workshop. The workshop will be held on July 10 and 11, 2017. Comments on the public workshop must be submitted on or before September 11, 2017 . . .